The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis-Reference-Cited by-同舟云学术

The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis

Published:2021-03-23 Issue:5 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Niesel Katja¹,Schulz Michael¹²,Anthes Julian¹,Alekseeva Tijna¹,Macas Jadranka³⁴,Salamero‐Boix Anna¹²,Möckl Aylin¹,Oberwahrenbrock Timm⁵⁶,Lolies Marco¹,Stein Stefan¹,Plate Karl H³⁴⁷,Reiss Yvonne³⁴⁷,Rödel Franz⁴⁷⁸,Sevenich Lisa¹⁴⁷^ORCID

Affiliation:

1. Institute for Tumor Biology and Experimental Therapy Georg‐Speyer‐Haus Frankfurt am Main Germany

2. Biological Sciences Faculty 15 Goethe University Frankfurt Frankfurt am Main Germany

3. Institute of Neurology (Edinger Institute) University HospitalGoethe University Frankfurt am Main Germany

4. Frankfurt Cancer Institute (FCI)Goethe University Frankfurt Frankfurt am Main Germany

5. Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) Frankfurt am Main Germany

6. Fraunhofer Cluster of Excellence Immune Mediated Diseases (CIMD) Frankfurt am Main Germany

7. German Cancer Consortium (DKTK)Partner Site Frankfurt/Mainz, Germany and German Cancer Research Center (DKFZ) Heidelberg Germany

8. Department of Radiotherapy and Oncology Goethe University Frankfurt Frankfurt am Main Germany

Funder

Deutsche Krebshilfe

Deutsche Forschungsgemeinschaft

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013412

Reference53 articles.

1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

2. HTSeq--a Python framework to work with high-throughput sequencing data

3. Immunosuppressive tumor‐infiltrating myeloid cells mediate adaptive immune resistance via a PD‐1/PD‐L1 mechanism in glioblastoma;Antonios JP;Neuro Oncol,2017

4. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas

5. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunity in malignant brain tumors: Tumor entities, role of immunotherapy, and specific contribution of myeloid cells to the brain tumor microenvironment;European Journal of Immunology;2023-12-11

2. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth;2023-11-15

3. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors;Frontiers in Immunology;2023-10-23

4. Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases;International Journal of Molecular Sciences;2023-07-27

5. Immunotherapy: an emerging modality to checkmate brain metastasis;Molecular Cancer;2023-07-15